Patients Partner Content Operationalize: Expanded Access Programs comes to the West C... Improving Global Access to Life-Changing Therapeutics...
R&D Partner Content 4th In Vivo Cell Engineering & Gene Editing Summit This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
Market Access Partner Content 6th Gene Therapy Analytical Development Summit Europe Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...
R&D Partner Content 13th Tumor Models Summit Boston | July 22-23, 2025 | Boston,... Improve preclinical tumor models to enhance translational oncology success.
R&D Partner Content 6th RNA Editing Summit | July 29-31, 2025 | Advance RNA Edit... The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies
Event Partner Content TPD & Induced Proximity Pharma Partnering Summit Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation pipeline or platform
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
